Modified radical mastectomy (removal of the entire breast with axillary dissection of levels I and II) with or without breast reconstruction.
To guide the selection of neoadjuvant or adjuvant therapy, many factors including stage, grade, and molecular status of the tumor (e.g., estrogen receptor [ER], progesterone receptor [PR], human epidermal growth factor type 2 receptor [HER2], or triple-negative status) are considered.[1-5] Selection of a local therapeutic approach depends on the following factors:[6] Location and size of the lesion.
Analysis of the mammogram and/or magnetic resonance imaging or additional imaging.